Recent publications · Crossref
5 total works indexed
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
· 2016 · cited 5,298x
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
· 2012 · cited 3,238x
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
· 2019 · cited 2,823x
- Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
· 2003 · cited 2,703x